Pulmatrix (PULM) Operating Expenses (2013 - 2026)
Pulmatrix (PULM) posted Operating Expenses of $1.3 million for Q1 2026, up 42.29% sequentially from $908000.0 in Q4 2025, and down 30.05% YoY from $1.8 million in Q1 2025.
Pulmatrix (PULM) Operating Expenses (2013 - 2026) Analysis & Trends
Pulmatrix has reported Operating Expenses for 14 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Operating Expenses fell 30.05% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 67.68% YoY) and the FY2025 annual result came in at $5.2 million, down 70.58% from the prior year.
- Operating Expenses improved to $1.3 million in Q1 2026 per PULM's latest filing, from $908000.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $7.5 million in Q2 2024 and troughed at $866000.0 in Q3 2025.
- A 5-year average of $4.2 million and a median of $5.1 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 34.1% in 2022, then sank 79.23% in 2025.
- Over 5 years, Operating Expenses stood at $6.0 million in 2022, then fell by 26.62% to $4.4 million in 2023, then plunged by 55.84% to $2.0 million in 2024, then tumbled by 53.55% to $908000.0 in 2025, then surged by 42.29% to $1.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.3 million, $908000.0, and $866000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 541.02 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 908,000.00 |
| Sep 30, 2025 | 866,000.00 |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 7.45 Mn |
| Mar 31, 2024 | 5.14 Mn |
| Dec 31, 2023 | 4.43 Mn |
| Sep 30, 2023 | 5.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 6.08 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 6.97 Mn |
| Jun 30, 2022 | 5.89 Mn |
| Mar 31, 2022 | 6.12 Mn |
| Dec 31, 2021 | 4.50 Mn |
| Sep 30, 2021 | 9.26 Mn |